DEF 14A

Company

Aptose Biosciences Inc.

Filed

May 8, 2019

Period of Report

June 4, 2019

Accession Number

0001171843-19-003129

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →